Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Halperin

Showing results (401-410 of 544) with videos related to

Pageof 55
Sort By:
Infection and Immunity|May 24, 2005
Infection of newborn piglets with Bordetella pertussis: a new model for pertussisS Elahi, R Brownlie, J Korzeniowski, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 27, 2001
Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59bX Qin, T Miwa, H Aktas, et al.
Journal of Clinical Microbiology|March 1, 1994
Identification of Bordetella pertussis infection by shared-primer PCRZ Li, D L Jansen, T M Finn, et al.
Vaccine|February 3, 2007
Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adultsShelly A McNeil, Francisco Noya, Marc Dionne, et al.
European Journal of Medicinal Chemistry|March 29, 2014
Structure-activity relationship study of 4EGI-1, small molecule eIF4E/eIF4G protein-protein interaction inhibitorsKhuloud Takrouri, Ting Chen, Evangelos Papadopoulos, et al.
The Journal of Infectious Diseases|October 4, 2016
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum AdjuvantJoanne M Langley, Naresh Aggarwal, Azhar Toma, et al.
Vaccine|December 23, 2023
An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) studyJoanne M Langley, Soren Gantt, Scott A Halperin, et al.
Vaccine|January 28, 2020
Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp)Julie A Bettinger, Paul Liberator, Scott A Halperin, et al.
BMC Public Health|December 6, 2025
The impact of two-year community-wide pharmacy interventions on the public's knowledge, attitudes, beliefs and behaviors about pharmacists as immunizersDonna M Halperin, Antonia M Di Castri, Jennifer E Isenor, et al.
Human Vaccines & Immunotherapeutics|April 11, 2013
Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccineScott A Halperin, Brian J Ward, Marc Dionne, et al.
Pageof 55

Showing results (401-410 of 544) with videos related to

Sort By:
Pageof 55
Infection and Immunity|May 24, 2005
Infection of newborn piglets with Bordetella pertussis: a new model for pertussisS Elahi, R Brownlie, J Korzeniowski, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 27, 2001
Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59bX Qin, T Miwa, H Aktas, et al.
Journal of Clinical Microbiology|March 1, 1994
Identification of Bordetella pertussis infection by shared-primer PCRZ Li, D L Jansen, T M Finn, et al.
Vaccine|February 3, 2007
Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adultsShelly A McNeil, Francisco Noya, Marc Dionne, et al.
European Journal of Medicinal Chemistry|March 29, 2014
Structure-activity relationship study of 4EGI-1, small molecule eIF4E/eIF4G protein-protein interaction inhibitorsKhuloud Takrouri, Ting Chen, Evangelos Papadopoulos, et al.
The Journal of Infectious Diseases|October 4, 2016
A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum AdjuvantJoanne M Langley, Naresh Aggarwal, Azhar Toma, et al.
Vaccine|December 23, 2023
An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) studyJoanne M Langley, Soren Gantt, Scott A Halperin, et al.
Vaccine|January 28, 2020
Estimated susceptibility of Canadian meningococcal B isolates to a meningococcal serogroup B vaccine (MenB-FHbp)Julie A Bettinger, Paul Liberator, Scott A Halperin, et al.
BMC Public Health|December 6, 2025
The impact of two-year community-wide pharmacy interventions on the public's knowledge, attitudes, beliefs and behaviors about pharmacists as immunizersDonna M Halperin, Antonia M Di Castri, Jennifer E Isenor, et al.
Human Vaccines & Immunotherapeutics|April 11, 2013
Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccineScott A Halperin, Brian J Ward, Marc Dionne, et al.
Pageof 55